Tufts University severs ties with family behind OxyContin
Members of the family that own OxyContin maker Purdue Pharma say they will push to reverse Tufts University's decision to strip their name from campus facilities and programs (Source: ABC News: Health)
Source: ABC News: Health - December 6, 2019 Category: Consumer Health News Tags: Health Source Type: news

Tufts University cuts ties with Purdue Pharma's Sackler family over opioid crisis
Tufts University is cutting ties with the billionaire family that owns OxyContin maker Purdue Pharma, saying it will strip the Sackler name from its campus and accept no further donations amid concerns over the family's role in the opioid crisis. (Source: CBC | Health)
Source: CBC | Health - December 5, 2019 Category: Consumer Health News Tags: News/Business Source Type: news

Judge: Purdue workers should get bonuses, but maybe not CEO
The judge overseeing the bankruptcy case of OxyContin maker Purdue Pharma says most of the company's employees should receive bonuses next year (Source: ABC News: Health)
Source: ABC News: Health - December 5, 2019 Category: Consumer Health News Tags: Health Source Type: news

Chronic opioid treatment may raise risk of post-traumatic stress disorder, study finds
While opioids are often prescribed to treat people with trauma-related pain, a new UCLA-led study suggests doctors should use caution before prescribing the drug to those they believe may experience severe stress in the future, in order to reduce the risk the patient will develop PTSD.In the study, researchers administered doses of the opioid morphine to a group of 22 mice for one week, then gave the mice relatively strong foot shocks. After the morphine wore off, the mice were given mild electric foot shocks. These mice showed a substantially longer “freezing response” than a second, control group of 24 mice that had ...
Source: UCLA Newsroom: Health Sciences - December 3, 2019 Category: Universities & Medical Training Source Type: news

States fight bonus pay for CEO of OxyContin maker Purdue
The chief executive officer of OxyContin-maker Purdue Pharma LP should not collect a potential $1.3 million bonus when he has been accused of contributing to the opioid epidemic, a group of state attorneys general said in a court filing on Monday. (Source: Reuters: Health)
Source: Reuters: Health - December 3, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Fake doctors, pilfered medical records drive Oxy China sales
Mundipharma reps have promoted OxyContin in China as less addictive than other opioids, the same pitch the company’s U.S. affiliate, Purdue Pharma, admitted was false in court more than a decade ago (Source: ABC News: Health)
Source: ABC News: Health - November 20, 2019 Category: Consumer Health News Tags: Health Source Type: news

AP key findings about Mundipharma’s OxyContin sales in China
Key findings of AP’s investigation about Mundipharma’s OxyContin sales in China (Source: ABC News: Health)
Source: ABC News: Health - November 20, 2019 Category: Consumer Health News Tags: Health Source Type: news

Fake doctors, misleading claims drive OxyContin China sales
Mundipharma reps have promoted OxyContin in China as less addictive than other opioids--the same pitch the company’s U.S. affiliate, Purdue Pharma, admitted was false in court more than a decade ago. (Source: ABC News: Health)
Source: ABC News: Health - November 20, 2019 Category: Consumer Health News Tags: Health Source Type: news

Mundipharma is promoting OxyContin in China with claims its U.S. affiliate, Purdue Pharma, admitted in court were false
(Source: ABC News: Health)
Source: ABC News: Health - November 20, 2019 Category: Consumer Health News Tags: Health Source Type: news

OxyContin maker Purdue Pharma to pay states' lawyers, urged to help victims
OxyContin maker Purdue Pharma LP got court approval on Tuesday to reimburse millions of dollars in legal fees for states that back its proposed $10 billion settlement of opioid lawsuits, but with a condition meant to help victims of the addiction crisis. (Source: Reuters: Health)
Source: Reuters: Health - November 20, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Walgreens' large role at height of opioid crisis is detailed in report
For six years beginning in 2006, Walgreens Boots Alliance Inc. was ordering 73 percent more oxycodone and hydrocodone pills per store on average compared with other pharmacies, according to a new report. The Washington Post reported on Thursdaythat during those six years, Walgreens was handling about 20 percent of all oxycodone and hydrocodone pills shipped to U.S. pharmacies. The report detailed Deerfield, Illinois-based Walgreens' (Nasdaq: WBA) purchased 13 billion opioid pills during those six … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 7, 2019 Category: Pharmaceuticals Authors: Ben Miller Source Type: news

Oxycodone vs. Vicodin (hydrocodone/acetaminophen) for Pain
Title: Oxycodone vs. Vicodin (hydrocodone/acetaminophen) for PainCategory: MedicationsCreated: 1/3/2017 12:00:00 AMLast Editorial Review: 11/7/2019 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - November 7, 2019 Category: Anesthesiology Source Type: news

Judge shields OxyContin-maker Purdue from litigation until April
Purdue Pharma LP and the company's Sackler family owners will be shielded until April 8, 2020, from sprawling opioid litigation to give the maker of OxyContin time to try to reach a legal settlement the company says is worth $10 billion. (Source: Reuters: Health)
Source: Reuters: Health - November 7, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Legal briefs: Opioid watchdog 'not surprised' by settlements
One of the Buffalo region ’s keynote watchdogs on the ongoing opioid lawsuits in New York and around the country wasn’t surprised to see the recent settlement that brought an end to more than 2,000 cases. Purdue Pharma, producers of OxyContin last month agreed to what’s expected to be the largest settlement yet at aro und $11 billion. Though some remain unsettled, it brought resolve to a plethora of cases consolidated in Ohio. “It should make anyone guardedly optimistic that they’re not… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 6, 2019 Category: Biotechnology Authors: Patrick Connelly Source Type: news

ASA: Unnecessary Opioids Often Prescribed After C-Section
MONDAY, Oct. 21, 2019 -- Opioids are commonly not needed but are overprescribed at discharge among women who undergo cesarean deliveries (CDs), and provider education and new order sets can reduce use of oxycodone for post-CD pain management,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 21, 2019 Category: Pharmaceuticals Source Type: news